News from Cardium Therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 27, 2014, 09:00 ET Cardium Announces Strategic Focus On Advanced Regenerative Therapeutics Based On Generx Clinical Findings

 Cardium Therapeutics Inc. (Ticker Symbol: CRXM) reported on the Company's strategic focus on its two advanced regenerative medicine...


Jan 24, 2014, 09:00 ET Cardium Common Stock To Begin Trading On The OTCQB Market

 As previously reported, Cardium Therapeutics, an advanced regenerative therapeutics company, today announced that its common stock will begin...


Dec 31, 2013, 09:00 ET Cardium Reports On Advancement Of Generx And Excellagen Biologic Products And Corporate Developments

Cardium Therapeutics (NYSE MKT: CXM) today reported on advancements of the Company's two key biologics products, its Generx® candidate for...


Dec 20, 2013, 09:00 ET Cardium Provides Update On Exchange Listing

Cardium Therapeutics (NYSE MKT: CXM) today provided an update on its exchange listing.  As previously reported, a communication from the staff...


Dec 04, 2013, 09:00 ET Cardium's Excellagen Assigned Q Code For Product Reimbursement

 Cardium Therapeutics (NYSE MKT: CXM) today announced that Cardium's Excellagen®, a wound care product indicated for the treatment of...


Dec 03, 2013, 09:00 ET LifeAgain's Bluemetric Select Life Insurance Now Offered At Lifequotes.com

 LifeAgain Insurance Solutions Inc., a wholly-owned subsidiary of Cardium Therapeutics (NYSE MKT: CXM), today announced that its BlueMetric...


Nov 19, 2013, 09:00 ET Cardium Reports On Third Quarter 2013 Financial Results And Recent Business Developments

Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the third quarter ended September 30, 2013, and reported on recent...


Nov 08, 2013, 09:00 ET Cardium Announces Publication On Use Of Excellagen For Managing Chronic Pressure Ulcers In Elderly Patients

Cardium Therapeutics (NYSE MKT: CXM) today announced the publication of a case study, "Serial Sharp Debridement and Formulated Collagen Gel to...


Oct 07, 2013, 10:27 ET Cardium Provides Update On Exchange Listing

Cardium Therapeutics (NYSE MKT: CXM) today provided an update on its exchange listing.  As previously reported, a communication from the...


Sep 27, 2013, 15:54 ET Unusual Trading Activity In Cardium Common Stock

Cardium Therapeutics (NYSE MKT: CXM) today released the following statement. In view of the unusual market activity in the Company's common...


Aug 14, 2013, 09:00 ET Cardium Reports On Second Quarter 2013 Financial Results And Recent Business Developments

Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the second quarter ended June 30, 2013, and reported on recent...


Aug 12, 2013, 09:00 ET Cardium Reports On Potential Use Of Excellagen To Repair Prenatally Diagnosed Birth Defects Using Mesenchymal Stem Cells

Cardium Therapeutics (NYSE MKT: CXM) today reported on a research collaboration with researchers at Boston Children's Hospital, to assess the...


Aug 07, 2013, 09:00 ET Cardium Announces Excellagen Distribution Agreement With Kasiak For Germany And Switzerland

 Cardium Therapeutics (NYSE MKT: CXM) today announced that it has entered into a distribution agreement with Kasiak Holdings AG for the...


Aug 05, 2013, 09:00 ET Cardium Announces New Excellagen FDA 510(k) Submission Based On Expanded Structural And Functional Properties

Cardium Therapeutics (NYSE MKT: CXM) today announced that it has filed a new 510(k) submission for its current FDA-cleared Excellagen®...


Aug 01, 2013, 09:00 ET Cardium Reports On New Excellagen Distribution Agreement With AvKARE For Veterans Hospitals And Other Governmental Medical Facilities

Cardium Therapeutics (NYSE MKT:CXM) today announced that it has entered into a distribution agreement with AvKARE Inc. to become the new sales and...


Jul 19, 2013, 09:00 ET Cardium Completes Preferred Stock Financing

 Cardium Therapeutics (NYSE MKT: CXM) today announced the completion of the second tranche of its previously described registered direct...


Jul 18, 2013, 09:00 ET Cardium Announces Reverse Stock Split

 Cardium Therapeutics (NYSE MKT: CXM) announced a 1-for-20 reverse split of the Company's issued and outstanding common stock effective at the...


Jul 02, 2013, 16:54 ET Cardium Announces Final Voting Results Of Annual Meeting Of Stockholders

Cardium Therapeutics (NYSE MKT: CXM) today reported the voting results of its reconvened annual meeting of stockholders held earlier...


Jun 21, 2013, 12:58 ET Cardium Announces Temporary Adjournment of Annual Meeting To Be Reconvened On July 2, 2013

Cardium Therapeutics (NYSE MKT: CXM) held its reconvened Annual Meeting of Stockholders earlier today and has temporarily adjourned the meeting to...


Jun 06, 2013, 12:43 ET Cardium Announces Initial Voting Results And Temporary Adjournment of Annual Meeting To Be Reconvened On June 21, 2013

Cardium Therapeutics (NYSE MKT: CXM) held its Annual Meeting of Stockholders earlier today.  The proposals considered at the Annual Meeting...


May 28, 2013, 09:00 ET Cardium Announces Favorable Recommendations From ISS And Glass Lewis For Annual Meeting Proposals

 Cardium Therapeutics (NYSE MKT: CXM) announced today that Institutional Shareholder Services, Inc. ("ISS") and Glass, Lewis & Co., LLC...


May 15, 2013, 09:00 ET Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments

Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the first quarter ended March 31, 2013, and reported on highlights...


May 02, 2013, 09:00 ET Cardium Announces Generx Publication In Molecular Therapy

 Cardium Therapeutics (NYSE MKT: CXM) today announced a publication, "Mechanistic, Technical, and Clinical Perspectives in Therapeutic...


Apr 30, 2013, 09:00 ET Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting

 Cardium Therapeutics (NYSE MKT: CXM) today announced that the Company will present a poster demonstrating the clinical benefits of...


Apr 05, 2013, 08:31 ET Cardium Presents Year-End 2012 Financial Results And Recent Developments

 Cardium Therapeutics (NYSE MKT: CXM) today presented highlights of financial results for fiscal year ended December 31, 2012, and...